Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Quality of Care
Researchers at Swansea University, South West Wales Cancer Institute target breast cancer quality of care
February 1st, 2007
Research findings, "Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer," are discussed in a new report. "Three hundred and ninety women participated in the quality of life (QL) study of ACCOG1, a high-dose vs conventional adjuvant chemotherapy breast cancer trial, for patients with a high risk of relapse. Patients completed the European Organisation for Research and Treatment of Cancer QLQ-C30, questions on menopausal symptoms and the Sexual Activity Questionnaire," researchers in Swansea, the United Kingdom report. "Pretreatment, 6,12, 24, 36, 48 and 60-month assessments were conducted. For the high dose group...
Source: Women's Health Weekly (2007-02-01)
|
